Published 1995 | Version v1
Report Open

Interim report on intrathoracic radiotherapy of human small-cell lung carcinoma in nude mice with Re-188-RC-160, a radiolabeled somatostatin analogue

  • 1. RhoMed Inc., Albuquerque, NM (United States)
  • 2. Univ. of Bonn (Germany). Dept. of Nuclear Medicine
  • 3. Oak Ridge National Lab., TN (United States). Health Sciences Research Div.

Description

The purpose of this study was to evaluate the therapeutic efficacy of Re-188-RC-160 in experimental models of human small cell lung carcinomas which mimic the clinical presentation. In the experimental model, cells from the human small cell lung carcinoma cell line NCI-H69 cells were inoculated into the thoracic cavity of athymic mice and rats. Subsequently, the biodistribution of Re-188-RC-160 after injection into the pleural cavity, a radiolabeled somatostatin analogue, was monitored as was the effect on the subsequent growth of tumors. The results presented here, and which are a part of a larger series of studies, suggest that Re-188-RC-160 can be effectively used in this animal model to restrict the growth of small cell lung carcinoma in the thoracic cavity

Availability note (English)

MF available from INIS under the Report Number; Also available from OSTI as DE95014289; NTIS; US Govt. Printing Office Dep.

Files

26076925.pdf

Files (430.9 kB)

Name Size Download all
md5:4c87e2c95fbc88c6d26ca42f62e9eaa2
430.9 kB Preview Download

Additional details

Publishing Information

Imprint Pagination
17 p.
Report number
CONF-9505232--2

Conference

Title
5. Mediterranean symposium on nuclear medicine and radiopharmaceuticals - receptors.
Dates
23-28 May 1995.
Place
Athens (Greece).

Optional Information

Contract/Grant/Project number
Contract AC05-84OR21400
Funding organization
USDOE, Washington, DC (United States).